			Home About us Contact

Percentage Reduction (percentage + reduction)

Distribution by Scientific Domains

Medical Sciences	68%
Life Sciences	18%
3 Other Domains	14%

Distribution within Medical Sciences

Dermatology	26%
General & Internal Medicine	13%

Selected Abstracts

Percentage reduction of pleural effusion as a simple predictor of pleural scarring in tuberculous pleuritis

RESPIROLOGY, Issue 4 2005
Chi-Fong WONG
Objective: The aim of the present study was to evaluate the utility of serum and pleural fluid biomarkers for predicting residual pleural scarring (RPS) in tuberculous pleuritis. Methodology: A retrospective study of patients with pleural tuberculosis was performed. Demographic data, clinical parameters, haematological indices, serum and pleural fluid biochemistry and pleural effusion area were assessed for correlation with the extent of RPS. Results: RPS was found in 41.4% of the 70 cases evaluated, with significant pleural scarring being present in 7.1%. It was more common in males (odds ratio 5.55). Among the variables studied, only the percentage reduction of the effusion after 2 weeks of treatment was found to independently predict the extent of RPS (r = ,0.502, P < 0.001). Conclusion: RPS was more common in males and the percentage reduction in pleural effusion on CXR after 2 weeks of treatment was found to be a useful predictor of RPS. [source]

Biomechanical consequences of an isolated overload on the human vertebral body

JOURNAL OF ORTHOPAEDIC RESEARCH, Issue 5 2000
David L. Kopperdahl
The biomechanical consequences of an isolated overload to the vertebral body may play a role in the etiology of vertebral fracture. In this context, we quantified residual strains and reductions in stiffness and ultimate load when vertebral bodies were loaded to various levels beyond the elastic regimen and related these properties to the externally applied strain and bone density. Twenty-three vertebral bodies (T11-L4, from 23 cadavers aged 20,90 years) were loaded once in compression to a randomized nominal strain level between 0.37 and 4.5%, unloaded, and then reloaded to 10% strain. Residual strains of up to 1.36% developed on unloading and depended on the applied strain (r2 = 0.85) but not on density (p = 0.25). Percentage reductions in stiffness and ultimate load of up to 83.7 and 52.5%, respectively, depended on both applied strain (r2 = 0.90 and r2 = 0.32, respectively) and density (r2 = 0.23 and r2 = 0.22, respectively). Development of residual strains is indicative of permanent deformations, whereas percentage reductions in stiffness are direct measures of effective mechanical damage. These results therefore demonstrate that substantial mechanical damage,which is not visible from radiographs,can develop in the vertebral body after isolated overloads, as well as subtle but significant permanent deformations. This behavior is similar to that observed previously for cylindrical cores of trabecular bone. Taken together, these findings indicate that the damage behavior of the lumbar and lower thoracic vertebral body is dominated by the trabecular bone and may be an important factor in the etiology of vertebral fracture. [source]

Effects of Botulinum Toxin Type A on Contouring of the Lower Face

DERMATOLOGIC SURGERY, Issue 5 2005
Seong Wook Choe MD
background. Masseteric muscle hypertrophy is an uncommon condition represented as a swelling of the masseter muscle. Recent reports have demonstrated the successful use of botulinum in the treatment of masseteric hypertrophy. objective. This study was a prospective trial to evaluate the effectiveness of botulinum toxin type A (Botox) in the treatment of masseteric muscle hypertrophy according to doses of 10, 20, and 30 U. materials and methods. Twenty-two patients were referred to the dermatologic clinic for the management of masseteric muscle hypertrophy. Ultrasonographic measurements of the thickness of the masseter muscle were performed, and clinical photographs were taken before treatment and 1, 2, 3, 4, 6, and 9 months after the treatment. results. The median values of percentage reduction of muscle mass were 10.3%, 16.5%, 23.7%, 24.7%, 21.6%, 16.5% in the 10 U group; 11.9%, 18.8%, 24.8%, 27.7%, 26.7%, and 21.8% in the 20 U group; and 12.0%, 19.4%, 25.0%, 27.8%, 37.8%, and 24.1% in the 30 U group. conclusion. The adequate dose of botulinum toxin type A for treatment of masseteric muscle hypertrophy should be above 20 U. The effect of botulinum toxin type A is maintained for at least 9 months as the treatment of masseteric muscle hypertrophy. [source]

Maternal memory in adult, nulliparous rats: Effects of testing interval on the retention of maternal behavior

DEVELOPMENTAL PSYCHOBIOLOGY, Issue 1 2005
Robert S. Bridges
Abstract The retention of maternal behavior (i.e., maternal memory) was measured in adult, nulliparous rats induced to respond maternally by continuous exposure to foster pups. Specifically, the effects of the interval duration between the initial induction and the reinduction of maternal behavior were determined. Intact virgin rats were first exposed to foster young to induce maternal behavior. During the initial induction phase, females were required to be fully maternal on 2 consecutive test days. Animals were then assigned to one of three interval groups (10, 20, or 40 days). After being isolated from rat pups for these designated periods, females in each group were tested again for their latencies to induce maternal behavior. Whereas the initial median latencies to display full maternal behavior ranged from 4.5 to 5 days for each group, upon retesting, median latencies for each group declined to 1 to 4 days. The greatest reduction in latency was present in the 10-day group (80%), and the smallest reduction was detected in the 40-day group (20%). A significant negative linear correlation was found between test interval and percentage reduction in behavioral latency. Based upon this relationship and under these test conditions, "maternal memory" in the adult, nulliparous rat would be expected to be nondetectable after about an interval of 50 days between tests. The pattern of maternal memory acquisition and loss appears similar to that reported in parous animals. The present study highlights similarities and possible differences underlying the establishment of the retention of maternal behavior (i.e., maternal memory). © 2004 Wiley Periodicals, Inc. Dev Psychobiol 46: 13,18, 2005. [source]

Aspirin reduces anticardiolipin antibodies in patients with coronary artery disease

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, Issue 12 2006
I. Ikonomidis
Abstract Background, Anticardiolipin antibodies (aCL) have been found to be elevated in patients with coronary artery disease (CAD) and have been associated with an adverse outcome owing to their prothrombotic activity. The aim of this study was to investigate the effect of aspirin treatment on aCL levels in patients with chronic CAD. Materials and methods, Forty patients with chronic CAD scheduled for elective coronary artery bypass graft surgery (CABG) and 40 healthy controls participated in the study. Patients were treated with 300 mg of aspirin once daily (o.d.) for the first 12 days and placebo for the following 12 days before CABG in a double-blind, cross-over trial. Immunoglobulin (Ig) G-, IgM-, IgA-aCL and C-reactive protein (CRP) levels were measured in the controls and at the end of each treatment period in the patients with CAD. Results, The IgA- and IgG-aCL levels were greater in patients with CAD than in the controls. Compared with the placebo, IgA, IgG subtypes and CRP levels were reduced after aspirin treatment (P = 0·001, P = 0·02, P = 0·04, respectively). The percentage reduction of IgA- and IgG-aCL was related to the percentage reduction of CRP after aspirin (P < 0·05). Conclusion, Aspirin treatment with 300 mg o.d. reduced the serum levels of IgA and IgG subtypes in patients with chronic CAD in parallel to a reduction in CRP. These findings offer an additional pathophysiological mechanism of the beneficial effects of aspirin in patients with chronic CAD. [source]

Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury

HEMODIALYSIS INTERNATIONAL, Issue 4 2009
Shvan KORSHEED
Abstract Native arteriovenous fistulae (AVF) remain the vascular access of choice for hemodialysis (HD). Despite being associated with superior long-term outcomes (cf. catheter use), little is known about the systemic hemodynamic consequences of AVFs. Repetitive myocardial injury (myocardial stunning) is an under-recognized common consequence of HD. The aim of this study was to examine the impact of AVF flow (Qa) on dialysis-induced cardiac injury. We studied 50 chronic HD patients. All patients underwent echocardiography (and subsequent quantitative offline analysis) at baseline, during and post dialysis, to assess left ventricular function and the development of regional wall motion abnormalities. Qa was measured using ionic dialysance. Patients were divided into Qa tertiles (<500, mean 291±101 mL/min, 500,1000, mean 739±130 mL/min and >1000, mean 1265±221 mL/min). There were no significant differences between the groups in terms of age, sex, diabetes, or resting ejection fraction. Patients with Qa>1000 mL/min had a lower prevalence of left ventricular hypertrophy (55% vs. 76%, P=0.01). Dialysis-induced myocardial stunning (seen in 65% of the patients studied) was significantly and sequentially reduced in those patients with higher Qas. This was seen in a lower number of segments and ventricular regions developing regional wall motion abnormalities, as well as a significantly reduced mean and cumulative percentage reduction in fractional shortening of those ventricular segments affected (,187±37%, ,161±26%, and ,101±25%, respectively, P=0.04). Relatively higher AVF flows appear to be associated with a lower level of observed HD-induced cardiac injury. [source]

Evaluation of the Personal Dental Services (Wave 1) for Lambeth, Southwark and Lewisham Primary Care Trusts , Part 2: Retrospective analyses of treatment and other dental record data

JOURNAL OF EVALUATION IN CLINICAL PRACTICE, Issue 3 2005
Helen Best BDS MDS PhD
Abstract Aim/Objective, The purpose of the study was to undertake analyses of treatment data for the Personal Dental Services (PDS) of Lambeth, Southwark and Lewisham Primary Care Trusts and relate the analyses to the PDS goals of supporting practitioners deliver appropriate quality dental care and ensuring that appropriate quality safety net services are available for all residents. Method, Analyses of treatment data provided by the Dental Practice Board were undertaken for the post-PDS period (February 1999,March 2003, based on data availability). Analyses of the clinic notes for 1500 patients were also undertaken for the 1 year pre-PDS period (October 1997,September 1998) and post-introduction of the PDS (October 1998,June 2003). Two sets of analyses were undertaken to evaluate trends in treatment claims for the Dental Practice Board data, absolute numbers of each type of treatment claimed each month and change in numbers of types of treatments claimed over time. The clinic notes were used to undertake post-PDS, pre-PDS comparisons of the number of treatment items and grouped treatment item categories undertaken and the number of courses and percentages of private treatment items provided. The following sociodemographic characteristics of the patients were also analysed, age, gender, exemption ,status ,and ,attendance ,status. Results, Overall it was identified that the percentage reduction in the number of treatment items undertaken was 13% (95% CI ,19%, ,7%), post- as compared to the pre-PDS introduction period. On an annual basis it was identified that the percentage reduction in the number of treatment items undertaken per year per patient post-PDS was 4% (95% CI ,6%, ,2%). There were significant variations in the impact of the PDS on the number of treatment items undertaken for different types of patients. A limited number of treatment types changed significantly post- as compared to pre-PDS. The proportion of exempt patients treated did not increase ,post-PDS. Conclusions, It is possible that a less, invasive style of dental treatment was provided during the course of the PDS, however, there was only limited evidence to indicate that dentists practice style changed based on types of treatment categories provided. The PDS provided a limited safety net service for local residents. In setting program goals the nature of quality dental practice requires definition and evaluation should be undertaken on a prospective basis. [source]

Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling

NEUROUROLOGY AND URODYNAMICS, Issue 1 2007
Christian O. Twiss
Abstract Aims We assessed the utility of three self-assessment instruments: the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), the post-operative Patient Global Impression of Improvement (PGI-I) score, and the International Prostate Symptom Score (IPSS) by correlating them with an objective outcome, the change in 24-hr pad weight, after a male perineal sling. Methods Twenty-six men with urodynamically confirmed stress incontinence underwent a male perineal sling. Patients were evaluated pre-operatively and post-operatively with a 24-hr pad test, IPSS and ICIQ-SF. Patients also completed the PGI-I post-operatively. Changes in study parameters were compared via the paired t -test, and correlations were performed using Spearman's rho. Results There were significant reductions in 24-hr pad weight (,274 g, P,<,0.001), percentage 24-hr pad weight (54.2%), ICIQ-SF score (,6.3, P,<,0.001), and the three ICIQ-SF subscores (,1.2, ,1.7, ,3.4 for Questions 3, 4, and 5, respectively, P,<,0.001 for all). The change in total ICIQ-SF score and the post-operative PGI-I score correlated strongly with percentage reduction in 24-hr pad weight (r,=,,0.68, P,<,0.001; r,=,,0.81, P,<,0.001, respectively) and with each other (r,=,0.79, P,<,0.001). The change in all three ICIQ-SF subscores correlated significantly with percentage reduction in 24-hr pad weight and with post-operative PGI-I score. There was no significant change in the IPSS or the voiding or storage subscores, and none correlated with any other study parameter. Conclusions This study validates the construct validity of the ICIQ-SF and PGI-I in the assessment of treatment for male stress incontinence and should make clinicians confident in comparing studies of incontinence treatment utilizing the change ICIQ-SF score, the post-operative PGI-I score, and percentage reduction in 24-hr pad weight as outcome measures. Neurourol. Urodynam. © 2006 Wiley-Liss, Inc. [source]

Northern Environment Predisposes Birches to Ozone Damage

PLANT BIOLOGY, Issue 2 2007
E. Oksanen
Abstract: Ozone sensitivity of silver birch (Betula pendula Roth) has been thoroughly investigated since early 1990,s in Finland. In our long-term open-field experiments the annual percentage reduction in basal diameter and stem volume increment were the best non-destructive growth indicators for ozone impact when plotted against AOTX. Remarkable differences in defence strategies, stomatal conductance, and defence compounds (phenolics), clearly indicate that external exposure indices are ineffective for accurate risk assessment for birch. For flux-based approaches, site-specific values for gmax and gdark are necessary, and determinants for detoxification capacity, ageing of leaves, and cumulative ozone impact would be needed for further model development. Increasing CO2 seems to counteract negative ozone responses in birch, whereas exposure to springtime frost may seriously exacerbate ozone damage in northern conditions. Therefore, we need to proceed towards incorporating the most important climate change factors in any attempts for ozone risk assessment. [source]

Planning-level source decay models to evaluate impact of source depletion on remediation time frame

REMEDIATION, Issue 4 2005
Charles J. Newell
A recent United States Environmental Protection Agency (US EPA) Expert Panel on Dense Nonaqueous Phase Liquid (DNAPL) Source Remediation concluded that the decision-making process for implementing source depletion is hampered by quantitative uncertainties and that few useful predictive tools are currently available for evaluating the benefits. This article provides a new planning-level approach to aid the process. Four simple mass balance models were used to provide estimates of the reduction in the remediation time frame (RTF) for a given amount of source depletion: step function, linear decay, first-order decay, and compound. As a shared framework for assessment, all models use the time required to remediate groundwater concentrations below a particular threshold (e.g., goal concentration or mass discharge rate) as a metric. This value is of interest in terms of providing (1) absolute RTF estimates in years as a function of current mass discharge rate, current source mass, the remediation goal, and the source- reduction factor, and (2) relative RTF estimates as a fraction of the remediation time frame for monitored natural attenuation (MNA). Because the latter is a function of the remediation goal and the remaining fraction (RF) of mass following remediation, the relative RTF can be a valuable aid in the decision to proceed with source depletion or to use a long-term containment or MNA approach. Design curves and examples illustrate the nonlinear relationship between the fraction of mass remaining following source depletion and the reduction in the RTF in the three decay-based models. For an example case where 70 percent of the mass was removed by source depletion and the remediation goal (Cg/C0) was input as 0.01, the improvement in the RTF (relative to MNA) ranged from a 70 percent reduction (step function model) to a 21 percent reduction (compound model). Because empirical and process knowledge support the appropriateness of decay-based models, the efficiency of source depletion in reducing the RTF is likely to be low at most sites (i.e., the percentage reduction in RTF will be much lower than the percentage of the mass that is removed by a source-depletion project). Overall, the anticipated use of this planning model is in guiding the decision-making process by quantifying the relative relationship between RTF and source depletion using commonly available site data. © 2005 Wiley Periodicals, Inc. [source]

Percentage reduction of pleural effusion as a simple predictor of pleural scarring in tuberculous pleuritis

Migraine-Related Vertigo: Diagnostic Criteria and Prophylactic Treatment

THE LARYNGOSCOPE, Issue 10 2006
Arturo Maione MD
Abstract Objective/Hypothesis: The objective of this prospective, observational study was to evaluate the efficacy of migraine pharmacologic prophylaxis on a group of vertiginous patients considered affected by migraine-related vertigo on the basis of precise criteria of inclusion. Methods: Fifty-three patients affected by migraine-related vertigo were selected from a cohort of 652 vertiginous patients referred to our Dizziness Unit from March 2001 to June 2005. Inclusion criteria were at least five vertigo attacks occurred in any period of time or dizziness and/or positional vertigo for at least 6 months; migraine, past or present, and/or a family history of migraine and/or motion intolerance; and exclusion of other causes. Patients were submitted to migraine pharmacologic prophylaxis selected on the basis of the characteristics of the patients and of the drug side effects. The efficacy of the treatment was evaluated after 6 months by questionnaire divided into five outcome categories (resolution, substantial control, moderate control, minimal control, no improvement or worsening) and, for the patients with recurrent vertiginous attacks, also reporting the percentage reduction of the attack frequency. Results: Thirty-six patients completed the study and were submitted to analysis of the results: 10 reported complete resolution of symptoms, 15 substantial control, 7 moderate control, one minimum control and 3 no improvement. Thirty-three of them had recurrent vertigo: 19 reported complete disappearance of the attacks, 8 reduction of the frequency >50%, 5 reduction <50%, and one no reduction. Conclusions: Migraine prophylactic treatment shows encouraging results in patients with migraine-related vertigo selected with our criteria of inclusion: 69.3% reported satisfactory control of symptoms (sum of complete resolutions and substantial controls) and 81.8% had at least a 50% reduction of the vertiginous episodes frequency. [source]

Production of Low-Lactose Milk by Means of Nonisothermal Bioreactors

BIOTECHNOLOGY PROGRESS, Issue 5 2004
Valentina Grano
The effect of the immobilization time on the activity of immobilized ,-galactosidase from K. lactis was investigated. Six biocatalytic membranes, different only for the time of the enzyme immobilization, were obtained by using nylon membranes grafted with glycidyl methacrylate (GMA) and activated by hexamethylenediamine (HMDA) and glutaraldehyde (Glu), used as spacer and coupling agent, respectively. Comparison between the isothermal and nonisothermal yield of these biocatalytic membranes was carried out in the process of lactose hydrolysis in milk. All of the results, reported as a function of the immobilization time, have evidenced the influence of our variable parameter on the activity of the catalytic membranes. The membrane giving highest yield under isothermal and nonisothermal conditions was that obtained with 2 h of immobilization time. The industrial application of these membranes has been discussed in terms of percentage reduction of the production times. [source]

Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients

BRITISH JOURNAL OF DERMATOLOGY, Issue 1 2006
C.M. Lawrence
Summary Background, Limited axillary skin excision and selective sweat gland removal from adjacent skin (Shelley's procedure) is currently rarely used for hyperhidrosis. Objectives, To determine whether this technique is a good way of permanently reducing axillary sweating. Methods, This was a prospective, open, nonrandomized trial of the therapy, conducted in a university dermatology department. A small skin ellipse, parallel to the skin crease lines, was excised from the centre of the area of maximal sweating. The wound edges were undermined to the extent of maximal sweating and the skin reflected. Large visible sweat glands attached to the undersurface of the adjacent skin could be readily identified and were snipped off using scissors. We treated 15 axillae in eight patients with axillary hyperhidrosis. Sweat reduction was assessed by the patients who estimated the percentage reduction in sweating postoperatively. The scar appearance was graded by the surgeon. Haematoxylin and eosin-stained transverse sections of eight axillary skin ellipses from five subjects were examined histologically to establish the size, position and depth of the sweat gland tissue. Results, All of the patients responded to treatment: mean sweat reduction was 65% (range 40,90%). Mean follow up was 1·3 years (range 0·1,6) and sweat reduction was maintained over this period. Histological material was available from five patients: sweat glands lay slightly deeper than hair follicles; glandular tissue occupied an average thickness of 3·5 mm in the 5-mm thick piece of skin. Apocrine gland lobules were more numerous and larger than eccrine gland lobules. Both gland types were in close apposition and did not occupy distinctly different depths within the skin. Conclusions, Local surgery using limited axillary skin excision and selective sweat gland removal remains one of the safest ways of permanently reducing axillary sweating. [source]

Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial

BRITISH JOURNAL OF DERMATOLOGY, Issue 6 2003
S.R. Mcbride
Summary Background Recent concerns over the side-effects of psoralen plus ultraviolet (UV) A, immunosuppressive and cytotoxic treatments have led to increased interest in dithranol for treatment of psoriasis. Few studies have investigated how frequently dithranol should be applied. Dithranol-induced inflammation is maximal at 48,72 h, suggesting that daily application of dithranol may not be optimal. Objectives To investigate the effectiveness of five times weekly application of short-contact dithranol (SCD) compared with three times weekly application in a dedicated hospital outpatient treatment unit. Methods A randomized, within-patient, controlled study was performed. Patients had SCD applied five times weekly to one half of the body, and three times weekly to the other side. Whole-body UVB irradiation was given 5 days a week. Patients were assessed weekly for 8 weeks. Principal outcome measures were percentage reduction in modified Psoriasis Area and Severity Index (mPASI) at the end of study and time to 50% improvement in mPASI score. Results Twenty-nine patients were recruited; four were excluded from analysis. Mean percentage reduction in mPASI score at the end of study for five times weekly application was 57·3% (95% confidence interval, CI 39·6,75·0%) and for three times weekly application was 55·4% (95% CI 37·8,73·1%; P = 0·34). Mean time to 50% improvement in mPASI for five times weekly treatment was 4·1 weeks and for three times weekly treatment was 4·0 weeks (P = 0·50). There was no difference in the frequency or severity of burning episodes for each side. Conclusions This study suggests that three times weekly application of SCD may be as effective as five times weekly when used in conjunction with UVB administered five times weekly. Large studies of whole-body comparisons are warranted to assess further the optimal frequency of SCD and UVB therapy for psoriasis. [source]

Influences of optic edge design on posterior capsule opacification and anterior capsule contraction

ACTA OPHTHALMOLOGICA, Issue 1 2007
Kazunori Miyata
Abstract. Purpose:, To investigate the influence of optic edge design on posterior capsule opacification (PCO) and anterior capsule contraction (ACC). Methods:, A total of 43 eyes of 43 patients scheduled to undergo cataract surgery were included in this study. Patients received either a Sensor® AR40 intraocular lens (IOL) or a Sensor® AR40e IOL. The area of the anterior capsule opening (ACO) was determined by diaphanoscopy using the anterior eye segment analysis system EAS-1000 at 1 day, 1 week and 1, 3, 6 and 12 months postoperatively. Posterior capsule opacification was evaluated objectively in two ways, using either the EAS-1000 or POCOman. Results:, There was no significant difference between the two groups in either ACO area or percentage reduction of ACO area at any time-point after surgery. The difference in the degree of PCO 1 year after surgery was not significant when measured by either the EAS-1000 or POCOman. Conclusions:, A sharp IOL edge is required to prevent PCO. Sharp-edged IOLs do not appear to be a risk factor for ACC. [source]

Inspiration-induced vasoconstrictive responses in dominant versus non-dominant hands

CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, Issue 2 2005
Harvey N. Mayrovitz
Summary Single rapid and deep inspirations (inspiratory gasps, IG) result in arteriolar vasoconstriction with concomitant transient decreases in skin blood flow that are most prominent in fingers and toes. Vascular responses (inspiratory gasp responses, IGR) are determined as the maximum percentage reduction in blood flow and have been used to assess sympathetic neurovascular function in several conditions. Previous studies have described various features of the response but there has been no reported systematic investigation of the degree of similarity between IGR obtained on dominant and non-dominant hands. This aspect is important in procedures that may use IGR to evaluate suspected unilateral sympathetic dysfunction of a limb-pair or to test the effectiveness of physiological interventions imposed on a single limb of a pair. Thus, the goal of our study was to compare IGR magnitudes that were simultaneously determined in paired-fingers of dominant and non-dominant hands. In 30 healthy seated subjects, skin blood perfusion via laser-Doppler (SBF) was measured on the dorsum of the middle finger of both hands while subjects performed three sequential IG at 3-min intervals. Analysis of variance for repeated measures revealed no significant difference in IGR between dominant (79·3 ± 11·2%) and non-dominant hands (81·9 ± 11·6%, P = 0·965) with an overall IGR of 80·6 ± 11·4%. These results indicate that hand-dominance is not a factor that is likely to significantly effect IGR differentials determined in paired-limbs. [source]

Demonstrating the clinical and cost effectiveness of adhesion reduction strategies

COLORECTAL DISEASE, Issue 5 2002
M. S. Wilson
Abstract Objective To examine the feasibility of conducting Randomized Controlled Trials (RCT) in lower abdominal surgery to demonstrate a reduction in adhesion-related admissions following use of an adhesion reduction product, and to model the cost effectiveness of such products. Methods The number of patients in each limb of a RCT comparing an adhesion reduction product to a control has been estimated based on 25% and 50% reductions in adhesion-related readmissions one year after surgery, for P = 0.05 at a power of 80% and P = 0.01 at a power of 90%. A cost effectiveness model based on the Surgical and Clinical Adhesions Research Group (SCAR) database has been developed which calculates the percentage reduction in readmissions required of an adhesion reduction product to return the cost of investment. It also estimates the cumulative costs of adhesion-related readmissions for lower abdominal surgery and the cost savings associated with an adhesion reduction policy using a low or high cost product. Results 7.2% of patients undergoing lower abdominal surgery will readmit due to adhesions in the first year after surgery. To demonstrate a 25% reduction in readmissions one year after surgery, it is calculated that a RCT would require between 5686 (P = 0.05, power = 80%) and 7766 (P = 0.01, power = 90%) lower abdominal surgery patients followed-up for one year. A cost effectiveness analysis demonstrates that routine use of adhesion reduction products costing £50 per patient will payback the cost of such investment if they reduce adhesion-related readmissions by 16% after 3 years. A product costing £200 will need to offer a 64.1% reduction in readmissions after 3 years. For the estimated 158 000 lower abdominal surgery operations conducted in the UK each year, the cumulative costs of adhesion-related readmissions over 10 years are estimated at £569 Million. Conclusion Demonstrating the clinical effectiveness of adhesion reduction products in the RCT setting is unlikely to be feasible due to the large number of patients required. Products costing £200 or more are unlikely to payback their direct costs. [source]

Influences of grass and moss on runoff and sediment yield on sloped loess surfaces under simulated rainfall

HYDROLOGICAL PROCESSES, Issue 18 2006
Chengzhong Pan
Abstract It is important to evaluate the impacts of grasses on soil erosion process so as to use them effectively to control soil and water losses on the Loess Plateau. Laboratory-simulated rainfall experiments were conducted to investigate the runoff and sediment processes on sloped loess surfaces with and without the aboveground parts of grasses and moss (GAM: grass and moss; NGAM: no grass and moss) under slope gradients of 5°, 10°, 15°, 20°, 25° and 30°. The results show that runoff from GAM and NGAM plots increased up to a slope gradient of 10° and decreased thereafter, whereas the runoff coefficients increased with gradient. The average runoff rates and runoff coefficients of NGAM plots were less than those of GAM plots except for the 5° slope. This behaviour may be due to the reduction in water infiltration under moss. The difference between GAM and NGAM plots in average runoff rates varied from 1·4 to 8%. At the same gradients, NGAM plots yielded significantly (, = 0·05) more sediment than GAM plots. Average sediment deliveries for different slopes varied from 0·119 to 3·794 g m,2 min,1 from GAM plots, and from 0·765 to 16·128 g m,2 min,1 from NGAM plots. Sediment yields from GAM plots were reduced by 45 to 85%, compared with those from the NGAM plots. Plots at 30° yielded significantly higher sediments than at the other gradients. Total sediments S increased with slope gradients G in a linear form, i.e. S = 9·25G , 39·6 with R2 = 0·77*, for the GAM plots, and in an exponential model, i.e. S = 40·4 exp(0·1042G) with R2 = 0·93**, for the NGAM plots. In all cases, sediment deliveries decreased with time, and reached a relative steady state at a rainfall duration of 14 min. Compared with NGAM plots, the final percentage reductions in sediment delivery from GAM plots were higher than those at the initial time of rainfall at all slopes. Copyright © 2006 John Wiley & Sons, Ltd. [source]

Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, Issue 10 2008
D. Lütjohann
Summary Objective:, To assess the long-term efficacy and safety profile of ezetimibe 10 mg/day in patients with homozygous sitosterolemia. Methods:, This was an extension of a multi-centre, randomised, double-blind, placebo-controlled base study in which patients with homozygous sitosterolemia and plasma sitosterol concentrations > 5 mg/dl were randomised 4 : 1 to ezetimibe 10 mg/day (n = 30) or placebo (n = 7) for 8 weeks. Patients who successfully completed the base study with > 80% compliance to study medication were eligible to enter two, successive, 1-year extension studies in which ezetimibe 10 mg/day was administered in an open-label manner. Patients remained on their current treatment regimen (e.g. bile salt-binding resins, statins and low-sterol diet) during the base and extension studies. Patients had to be off ezetimibe therapy for , 4 weeks prior to entering the first extension. Efficacy and safety/tolerability parameters were evaluated every 12 and 26 weeks in the first and second years respectively. The primary efficacy end-point was mean percentage change in plasma sitosterol from baseline to study end for the cohort of patients (n = 21) who successfully completed the second extension study. Results:, Treatment with ezetimibe 10 mg/day led to significant mean percentage reductions from baseline in plasma concentrations of sitosterol (,43.9%; p < 0.001), campesterol (,50.8%; p < 0.001), low-density lipoprotein (LDL) sterols (,13.1%; p < 0.050), total sterols (,10.3%; p < 0.050) and apolipoprotein (apo) B (,10.1%; p < 0.050). No significant changes from baseline were observed for lathosterol, high-density lipoprotein sterol, triglycerides or apo A-1. Maximal reductions in sitosterol and campesterol occurred within the first 52 weeks of treatment and were sustained for the duration of the study. For LDL sterol, total sterols and apo B, maximal reductions were achieved early (by weeks 4 or 16) and waned slightly through the remainder of the study. Overall ezetimibe 10 mg was well tolerated. Conclusion:, In patients with homozygous sitoserolemia, long-term treatment with ezetimibe 10 mg/day for 2 years was effective in reducing plasma plant sterol concentrations with an overall favourable safety and tolerability profile. [source]